Adedoyin D. Abraham

Design of an Amide <i>N</i>-Glycoside Derivative of β-Glucogallin: A Stable, Potent, and Specific Inhibitor of Aldose Reductase

Linfeng Li, Kun‐Che Chang, Yaming Zhou et al. · Journal of Medicinal Chemistry · 2013 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer

Joshua M. Abbott, Qiong Zhou, Hector Esquer et al. · Molecular Cancer Therapeutics · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer

Qiong Zhou, Adedoyin D. Abraham, L Li et al. · Oncogene · 2016 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +16

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer

Hector Esquer, Qiong Zhou, Travis Nemkov et al. · Oncogene · 2021 · 23 citations · Full text

Medicine, Cancer Biology, Oncology +16

Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition

Jessica Ponder, Byong Hoon Yoo, Adedoyin D. Abraham et al. · Marine Drugs · 2011 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15